Funding & Support

Crinetics Pharmaceuticals is committed to raising awareness of endocrine diseases and supporting research projects and awareness initiatives for related symptoms and treatments. Accordingly, we provide medical education grants and research funding to qualified researchers for investigator-initiated studies (IIS).

Medical Education Grants

Healthcare organizations and professionals can apply for a medical education grant to support bonafide educational programs and activities related to disease awareness and improvement of patient care. To be eligible, applicants must meet the following requirements:

Demonstrate that the proposed medical education provided through the grant will promote improved delivery of healthcare.
Be an independent, accredited medical educator that conforms to FDA and ACCME standards.
The proposed medical education is not satisfied under existing programs.
Must complete an agreement with Crinetics.

Crinetics invites accredited educational providers to submit applications for independent, certified medical education grants subject to the terms described below. This Request for Proposals (RFP) provides public notice of the availability of funds in a general topic area for activities for which recognized scientific or educational needs exist and funding is available.

Title: AACE 2026: Acromegaly Management and Considerations of Clinical Guidelines and Therapies
Application Due Date: December 8, 2025; 5:00 PM PT

Apply

For any questions, please contact [email protected].

Investigator Initiated Studies (IIS)

Crinetics supports independent research through its Investigator-Initiated Studies (IIS) program. These grants provide funding and/or product support for studies that advance disease understanding and explore potential treatments in Crinetics’ areas of interest, with the goal of improving patient care. Crinetics reviews unsolicited proposals from healthcare professionals, scientists, researchers, and institutions seeking research support.

You may qualify if you meet the following requirements:

Deliverables are tangible and follow scientific methods.
Crinetics’ support of the research must be clearly acknowledged and disclosed in all publication of study data and results.
The IIS applicant is solely responsible and exercises full control of the execution and planning of the study.
Must complete an agreement with Crinetics.
Research demonstrates alignment with Crinetics’ research areas of interest.

Crinetics is happy to consider investigator-initiated research proposals relevant to these disease states, in the following areas:

Paltusotine

Pathophysiologic Profiling: Further characterize and understand the underlying pathophysiology of acromegaly including the identification of emerging biomarkers that reflect disease activity, symptomology, and progression.
Patient Journey: Enhance the acromegaly patient journey by improving early diagnosis, optimizing treatment pathways, and supporting daily disease management through real-world evidence and personalized care strategies.
Patient Centered Insights: Advance understanding of the patient and caregiver experience by evaluating patient-reported outcomes (such as symptom burden, quality of life, and perceived barriers to care), measures of caregiver burden, and correlations between these patient-reported outcomes and clinical biomarkers.
Broaden Clinical Potential: Explore the potential of paltusotine in additional disease areas and patient populations, investigate biomarkers and symptoms not assessed in current studies, and evaluate the impact of combination therapies on clinical outcomes.

Apply

For any questions, please contact [email protected].